Literature DB >> 25866245

PTEN functions by recruitment to cytoplasmic vesicles.

Adam Naguib1, Gyula Bencze1, Hyejin Cho1, Wu Zheng1, Ante Tocilj2, Elad Elkayam3, Christopher R Faehnle2, Nadia Jaber4, Christopher P Pratt1, Muhan Chen1, Wei-Xing Zong4, Michael S Marks5, Leemor Joshua-Tor3, Darryl J Pappin1, Lloyd C Trotman6.   

Abstract

PTEN is proposed to function at the plasma membrane, where receptor tyrosine kinases are activated. However, the majority of PTEN is located throughout the cytoplasm. Here, we show that cytoplasmic PTEN is distributed along microtubules, tethered to vesicles via phosphatidylinositol 3-phosphate (PI(3)P), the signature lipid of endosomes. We demonstrate that the non-catalytic C2 domain of PTEN specifically binds PI(3)P through the CBR3 loop. Mutations render this loop incapable of PI(3)P binding and abrogate PTEN-mediated inhibition of PI 3-kinase/AKT signaling. This loss of function is rescued by fusion of the loop mutant PTEN to FYVE, the canonical PI(3)P binding domain, demonstrating the functional importance of targeting PTEN to endosomal membranes. Beyond revealing an upstream activation mechanism of PTEN, our data introduce the concept of PI 3-kinase signal activation on the vast plasma membrane that is contrasted by PTEN-mediated signal termination on the small, discrete surfaces of internalized vesicles.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25866245      PMCID: PMC4423730          DOI: 10.1016/j.molcel.2015.03.011

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  68 in total

Review 1.  The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond.

Authors:  Sarah F Funderburk; Qing Jun Wang; Zhenyu Yue
Journal:  Trends Cell Biol       Date:  2010-03-29       Impact factor: 20.808

2.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

3.  Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.

Authors:  Clare G Fedele; Lisa M Ooms; Miriel Ho; Jessica Vieusseux; Sandra A O'Toole; Ewan K Millar; Elena Lopez-Knowles; Absorn Sriratana; Rajendra Gurung; Laura Baglietto; Graham G Giles; Charles G Bailey; John E J Rasko; Benjamin J Shields; John T Price; Philip W Majerus; Robert L Sutherland; Tony Tiganis; Catriona A McLean; Christina A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-02       Impact factor: 11.205

4.  Subtle variations in Pten dose determine cancer susceptibility.

Authors:  Andrea Alimonti; Arkaitz Carracedo; John G Clohessy; Lloyd C Trotman; Caterina Nardella; Ainara Egia; Leonardo Salmena; Katia Sampieri; William J Haveman; Edi Brogi; Andrea L Richardson; Jiangwen Zhang; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

5.  Structure of the PTEN-like region of auxilin, a detector of clathrin-coated vesicle budding.

Authors:  Rong Guan; Han Dai; Dai Han; Stephen C Harrison; Tomas Kirchhausen
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

Review 6.  Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway.

Authors:  Elisabeth Fayard; Gongda Xue; Arnaud Parcellier; Lana Bozulic; Brian A Hemmings
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding.

Authors:  Holly C Dippold; Michelle M Ng; Suzette E Farber-Katz; Sun-Kyung Lee; Monica L Kerr; Marshall C Peterman; Ronald Sim; Patricia A Wiharto; Kenneth A Galbraith; Swetha Madhavarapu; Greg J Fuchs; Timo Meerloo; Marilyn G Farquhar; Huilin Zhou; Seth J Field
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

8.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.

Authors:  Christina Gewinner; Zhigang C Wang; Andrea Richardson; Julie Teruya-Feldstein; Dariush Etemadmoghadam; David Bowtell; Jordi Barretina; William M Lin; Lucia Rameh; Leonardo Salmena; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

Review 9.  Phosphoinositide phosphatases in cell biology and disease.

Authors:  Yang Liu; Vytas A Bankaitis
Journal:  Prog Lipid Res       Date:  2010-01-05       Impact factor: 16.195

Review 10.  Non-genomic loss of PTEN function in cancer: not in my genes.

Authors:  Nick R Leslie; Michelangelo Foti
Journal:  Trends Pharmacol Sci       Date:  2011-01-13       Impact factor: 14.819

View more
  36 in total

1.  Cancer: Precise control of localized signals.

Authors:  Vuk Stambolic
Journal:  Nature       Date:  2015-05-27       Impact factor: 49.962

2.  Phosphatidylinositol-3-OH kinase signalling is spatially organized at endosomal compartments by microtubule-associated protein 4.

Authors:  Narendra Thapa; Mo Chen; Hudson T Horn; Suyong Choi; Tianmu Wen; Richard A Anderson
Journal:  Nat Cell Biol       Date:  2020-11-02       Impact factor: 28.824

Review 3.  Phosphoinositide spatially free AKT/PKB activation to all membrane compartments.

Authors:  Narendra Thapa; Hudson Tyler Horn; Richard A Anderson
Journal:  Adv Biol Regul       Date:  2019-04-11

4.  PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex.

Authors:  Arman Javadi; Ravi K Deevi; Emma Evergren; Elodie Blondel-Tepaz; George S Baillie; Mark Gh Scott; Frederick C Campbell
Journal:  Elife       Date:  2017-07-27       Impact factor: 8.140

Review 5.  Oncogenic PTEN functions and models in T-cell malignancies.

Authors:  M Tesio; A Trinquand; E Macintyre; V Asnafi
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

6.  Loss of PTEN promotes formation of signaling-capable clathrin-coated pits.

Authors:  Luciana K Rosselli-Murai; Joel A Yates; Sei Yoshida; Julia Bourg; Kenneth K Y Ho; Megan White; Julia Prisby; Xinyu Tan; Megan Altemus; Liwei Bao; Zhi-Fen Wu; Sarah L Veatch; Joel A Swanson; Sofia D Merajver; Allen P Liu
Journal:  J Cell Sci       Date:  2018-04-26       Impact factor: 5.285

Review 7.  Phosphatidylinositol 3-phosphates-at the interface between cell signalling and membrane traffic.

Authors:  Andrea L Marat; Volker Haucke
Journal:  EMBO J       Date:  2016-02-17       Impact factor: 11.598

8.  Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity.

Authors:  Sebastián A Riquelme; Benjamin D Hopkins; Andrew L Wolfe; Emily DiMango; Kipyegon Kitur; Ramon Parsons; Alice Prince
Journal:  Immunity       Date:  2017-12-12       Impact factor: 31.745

9.  Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway.

Authors:  Haibin Wang; Dinah Loerke; Caroline Bruns; Rainer Müller; Philipp-Alexander Koch; Dmytro Puchkov; Carsten Schultz; Volker Haucke
Journal:  J Biol Chem       Date:  2019-12-12       Impact factor: 5.157

10.  microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer.

Authors:  Sharon Wang; Jeff C Liu; YoungJun Ju; Giovanna Pellecchia; Veronique Voisin; Dong-Yu Wang; Rajwinder Leha L; Yaacov Ben-David; Gary D Bader; Eldad Zacksenhaus
Journal:  JCI Insight       Date:  2017-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.